ArticleThe breast journal2023

Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.